Medicare Enrolled

Dr. Glenda Moheeputh, OD

Optometrist · Pembroke Pines, FL
Consulting-driven
19244 NW 12TH ST, Pembroke Pines, FL 33029
9548547910
In practice since 2017 (8 years)
NPI: 1689187676 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moheeputh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moheeputh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moheeputh

Dr. Glenda Moheeputh is an optometrist in Pembroke Pines, FL, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Moheeputh received a total of $118,213 from 23 pharmaceutical and/or device companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moheeputh is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice $118,213 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Optometrist 5490 Clear February 28, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$118,213
Total received (2018-2024)
Avg $16,888/year across 7 years
Top 1% in FL for optometrist
23
Companies
313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$74,675 (63.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,198 (33.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,340 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48,267
2023
$27,049
2022
$37,278
2021
$2,996
2020
$441
2019
$477
2018
$1,705

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Johnson & Johnson Vision Care, Inc.
$70,752
Alcon Vision LLC
$33,847
TOPCON MEDICAL SYSTEMS, INC.
$6,867
Topcon Healthcare, Inc.
$2,878
Alcon Laboratories Inc
$1,347
CooperVision Inc.
$507
ABBVIE INC.
$252
Sight Sciences, Inc.
$245
Dompe US, Inc.
$140
Oyster Point Pharma, Inc.
$140
MacuLogix, Inc.
$129
GENZYME CORPORATION
$125
Allergan Inc.
$124
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
Sun Pharmaceutical Industries Inc.
$118
Aerie Pharmaceuticals, Inc.
$118
BIOTISSUE HOLDINGS, INC.
$113
Johnson & Johnson Surgical Vision, Inc.
$111
Bausch & Lomb Americas Inc.
$105
Bausch & Lomb, a division of Bausch Health US, LLC
$82
BIOTISSUE HOLDINGS INC.
$38
Glaukos Corporation
$28
Reliance Medical Products, Inc.
$27
Top 3 companies account for 94.3% of total payments
Associated products mentioned in payments ›
Acuvue · AdaptDx · BIOTRUE ONE DAY · CEQUA · CEREZYME · Cequa · Clariti Contact Lens · DAILIES · DAILIES TOTAL1 · ILUX · INFUSE · LUMIGAN · MiSight Contact Lens · OCT-MAESTRO · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · Onefit Contact Lens · PROKERA · Paragon CRT · Precision 1 · Precision 7 · Rhopressa · TOTAL30 · TYRVAYA · Tecnis 1-piece IOL · VUITY · iStent Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for optometrist in FL.

Looking for an optometrist in Pembroke Pines?
Compare optometrists in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
843
Per 100K population
43.3
County median income
$74,534
Nearest hospital
MEMORIAL HOSPITAL MIRAMAR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Moheeputh is an optometrist, with consulting-driven industry engagement in the top 1% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Moheeputh receive payments from pharmaceutical companies?
Yes. Dr. Moheeputh received a total of $118,213 from 23 companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Moheeputh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →